Sinopharm Group Co. Ltd. | Ownership
Companies that own Sinopharm Group Co. Ltd.
OppenheimerFunds, Inc.
189,284,100
15.87%
-281,000
0.55%
07/31/2018
Matthews International Capital Management LLC
60,109,600
5.04%
1,703,200
0.95%
10/10/2017
Capital Research & Management Co. (World Investors)
42,110,000
3.53%
0
0.03%
12/31/2016
Mirae Asset Global Investments (Hong Kong) Ltd.
40,648,000
3.41%
0
10.14%
12/31/2016
FIL Investment Advisors (UK) Ltd.
38,698,000
3.24%
0
0.2%
06/20/2018
Invesco Canada Ltd.
37,149,613
3.11%
642,195
1.14%
06/29/2018
The Vanguard Group, Inc.
35,228,481
2.95%
-21,200
0.01%
07/31/2018
BlackRock Fund Advisors
22,895,600
1.92%
102,800
0.01%
07/25/2018
Templeton Investment Counsel LLC
21,295,176
1.79%
-1,604,400
0.49%
07/31/2018
Templeton Global Advisors Ltd.
19,800,551
1.66%
-830,800
0.25%
07/31/2018
| Address |
Sinopharm Plaza
Shanghai Shanghai 200051
China
|
|
Employees
|
- |
| Website |
http://www.sinopharmholding.com |
| Updated |
07/08/2019 |
| Sinopharm Group Co., Ltd. is a distributor of pharmaceutical and healthcare products and a value added supply chain service provider in the People's Republic of China. It operates through the following business segments: Pharmaceutical Distribution, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment provides distribution, logistics and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers and other suppliers. |
